Cargando…

Fixed drug combination in hypertension and hyperlipidaemia in the developing world

Detalles Bibliográficos
Autor principal:	Seedat, YK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Clinics Cardive Publishing 2008
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974502/ https://www.ncbi.nlm.nih.gov/pubmed/18568170

Ejemplares similares

Screening for Hyperlipidaemia in Childhood: Recommendations of the British Hyperlipidaemia Association
por: Wray, R, et al.
Publicado: (1996)

Perspectives on research in hypertension
por: Seedat, YK
Publicado: (2009)

Hyperlipidaemia: Diagnosis and Management
por: Betteridge, D J
Publicado: (1996)

Screening for Hyperlipidaemia in Childhood
por: O'Donohue, J M, et al.
Publicado: (1996)

Screening for Hyperlipidaemia in Childhood
por: Pearce, K E, et al.
Publicado: (1996)

Why is control of hypertension in sub-Saharan Africa poor?
por: Seedat, YK
Publicado: (2015)

Impact of poverty on hypertension and cardiovascular disease in sub-Saharan Africa
por: Seedat, YK
Publicado: (2007)

Peculiarities of hyperlipidaemia in tumour patients.
por: Dilman, V. M., et al.
Publicado: (1981)

DNA Markers in the Hyperlipidaemias and Atherosclerosis
por: Rees, A.
Publicado: (1987)

Lessons from treatment resistant hyperlipidaemia
por: Parsons, Elizabeth, et al.
Publicado: (2016)

Guidelines for the Management of Hyperlipidaemia in General Practice
por: Elkeles, R. S.
Publicado: (1992)

Triple fixed drug combinations in type 2 diabetes
por: John, Mathew, et al.
Publicado: (2015)

Fixed dose drug combinations: Issues and challenges in India
por: Gupta, Yogendra Kumar, et al.
Publicado: (2016)

South African hypertension practice guideline 2014
por: Seedat, YK, et al.
Publicado: (2014)

Statin use, hyperlipidaemia, and the risk of breast cancer
por: Kaye, J A, et al.
Publicado: (2002)

The Management of Hyperlipidaemia: Are Specialist Lipid Clinics Needed?
por: Roche, M., et al.
Publicado: (1992)

Treating Tuberculosis: Time to Introduce Fixed-Dose Drug Combinations
por: Manikandan, S
Publicado: (2012)

Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings
por: Chua, Siew Siang, et al.
Publicado: (2012)

Cholecystectomy or Cholelithiasis – a Missed Marker for Hyperlipidaemia? A Combined Retrospective and Prospective Study
por: Sabanathan, Sivakumaran, et al.
Publicado: (2008)

Combination of hyperglycaemia and hyperlipidaemia induces endothelial dysfunction: Role of the endothelin and nitric oxide systems
por: Abu‐Saleh, Niroz, et al.
Publicado: (2020)

Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
por: Zhou, Enchen, et al.
Publicado: (2020)

Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia
por: Ekor, Martins, et al.
Publicado: (2021)

Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus
por: Davey, Rachel A, et al.
Publicado: (2006)

Transient massive hyperlipidaemia in a type 2 diabetic subject
por: Vigna, G. B., et al.
Publicado: (2007)

Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis
por: Soehnlein, Oliver, et al.
Publicado: (2009)

Moving psychopharmacological drug development to the developing world
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2014)

The cost of coping: a cardio-neuro-metabolic risk for black South Africans?
por: Malan, Leoné, et al.
Publicado: (2010)

There may be a link between intrahepatic cholestasis of pregnancy and familial combined hyperlipidaemia: a case report
por: Ajala, Tosin, et al.
Publicado: (2009)

Rational approaches to the treatment of hypertension: drug therapy—monotherapy, combination, or fixed-dose combination?
por: Canbakan, Başol
Publicado: (2013)

Red meat consumption and its association with hypertension and hyperlipidaemia among adult Maasai pastoralists of Ngorongoro Conservation Area, Tanzania
por: Diarz, Ester J., et al.
Publicado: (2020)

Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia
por: Aung, Lynn Htet Htet, et al.
Publicado: (2014)

The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia
por: Vahit, Demir, et al.
Publicado: (2018)

Lopinavir/ritonavir: Hyperlipidaemia following off-label use: case report
Publicado: (2020)

Chronopharmacology of simvastatin on hyperlipidaemia in high‐fat diet‐fed obese mice
por: Li, Huan, et al.
Publicado: (2020)

Glucose inhibits haemostasis and accelerates diet-induced hyperlipidaemia in zebrafish larvae
por: Morris, Simone, et al.
Publicado: (2021)

Hypertension and Diabetes: Entry Points for Prevention and Control of the Global Cardiovascular Epidemic
por: Mendis, Shanthi, et al.
Publicado: (2013)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Whole blood viscosity assessment issues V: Prevalence in hypercreatinaemia, hyperglycaemia and hyperlipidaemia
por: Nwose, Ezekiel Uba
Publicado: (2010)

EFFECT OF HYPERLIPIDAEMIA ON REPRODUCTIVE ORGANS IN MALE ALBINO RABBITS : A HISTOLOGICAL APPROACH
por: Purohit, Ashok, et al.
Publicado: (2004)

Are patients undergoing treatment of hyperlipidaemia with statins the best candidates for early cardiac rehabilitation?
por: Celiński, Rafał, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oeauic96pmcuj3l578paf4i4g7